Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100.

Markus MöhlerMikhail DvorkinNarikazu Boku Mustafa ÖzgüroğluMin-Hee RyuAlina S MunteanSara LonardiMarina NechaevaArinilda C BragagnoliHasan S CoşkunAntonio Cubillo GracianToshimi Takano Rachel WongHoward SafranGina M VaccaroZev A WainbergMatthew R SilverHuiling XiongJanet HongGilles Manceau Yung-Jue Bang

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2020)

JAVELIN Gastric 100 did not demonstrate superior OS with avelumab maintenance versus continued chemotherapy in patients with advanced GC or GEJC overall or in a prespecified PD-L1-positive population.

Keyphrases

phase iii
locally advanced
clinical trial
open label
phase ii
double blind
study protocol
squamous cell carcinoma
placebo controlled
rectal cancer
radiation therapy
randomized controlled trial
high resolution
young adults
simultaneous determination